NCT00455559View on ClinicalTrials.gov

Ph II Study of Perifosine Plus Gleevec for Patients With GIST

PHASE2CompletedINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

November 30, 2010

Study Completion Date

October 31, 2011

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG

Perifosine

DRUG

Imatinib Mesylate

Sponsors

Lead Sponsor

AEterna Zentaris

All Listed Sponsors

collaborator

M.D. Anderson Cancer Center

OTHER

lead

AEterna Zentaris

INDUSTRY